Submitted by klmcguire on Tue, 03/24/2020 - 09:31
Display as a single page
Off
Tab
paragraphs
html blurb

The Department of Research and Development is responsible for the administrative aspects of all research projects at Carilion Clinic. This includes contracting, finance, regulatory compliance, grant management and the conduct of the trial, including research coordination. The department has a goal of increasing the quality and quantity of research studies through increased customer focus, education, streamlined processes and increased collaboration with internal and external partners.

Section Title
Our Mission
Use Section Title As Header
On
Tab Name
About Us
paragraphs
Tab Name
Clinical Trials
paragraphs
Tab Name
COVID-19 Research
paragraphs
html blurb

Carilion Clinic's Institutional Review Board and the Department of Research and Development want to assure that the safety of research participants and personnel is of utmost importance during the COVID-19 outbreak. Moreover, given that many of our human subjects research studies are co-located within our clinical operations, the safety and well-being of our patients, nurses, clinical staff and visitors must be considered in our research commencement process.  

All human subjects research activities that can be continued remotely should continue in that manner, and in-person research visits are recommended to take place only with participants who are also being seen in a clinical care visit. All new research study participants not seen in the context of a clinical care visit should be briefed on current Carilion Clinic COVID-19 processes and procedures for hospital employees and visitors before entering our facilities, including face coverings, social distancing and screening regarding their health status, vaccination status and prior travel location(s).

All research personnel and participants should consult with Carilion Clinic's current COVID-19 guidelines and practices at CarilionClinic.org/safe. Principal investigators must also be prepared to quickly reduce in-person research-related activities, if deemed necessary.

The ultimate decision and timing of lifting the pause for human subjects research is being left to each individual department, as it is understood that each department has different and unique challenges during this time. Lifting of the research pause will be considered on a study-by-study basis within the department through your department chair or departmental chair equivalent.  

Listed below are key personnel who can answer questions pertaining to current and future research studies.

Institutional Review Board and Human Research Protections

Carley Emerson: caemerson@carilionclinic.org or 540-769-7888
Charles J. Schleupner, M.D.: 
cjschleupner@carilionclinic.org or 540-420-7224

Research and Development
Francis Farrell: fxfarrell@carilionclinic.org or 540-589-8555

Clinical Research/Trials
Andrea Bidanset: albidanset@carilionclinic.org or 540-309-5693

Health Analytics
Mattie Tenzer: mmtenzer@carilionclinic.org or 540-529-4654

Office of Organizational Integrity and Compliance
Allison McKell: aomckell@carilionclinic.org or 540-510-4645

Section Title
Research COVID-19 Commencement Update
Use Section Title As Header
On
Tab Name
Research COVID-19 Memo
paragraphs
html blurb

In accordance with regulatory requirements, this web page provides public access to information pertaining to conflicts of interest (COIs) of externally funded or supported research.

The information on this web page will remain available for three (3) years after its most recent update. Information provided will include:

  1. The Covered Individual’s name
  2. The Covered Individual’s title and role with respect to the research
  3. The name of the entity in which the financial interest is held
  4. The nature of the financial interest that constitutes a financial COI
  5. The approximate value of the financial interest by range or, if the dollar value cannot be determined by reference to public prices or other reasonable measures of fair market value, a statement to that effect

A management plan is established in cooperation with the Covered Individual to address the COI per Carilion Clinic policy. The information posted on this website is derived from the management plan.

The information posted on this website is subject to updates on at least an annual basis and within 60 days of Carilion Clinic’s identification of the COI.

For more information or questions regarding any conflict of interest disclosures, please contact the Organizational Integrity and Compliance office at compliance@carilionclinic.org or 540-510-4573

 

M. Jonathan Bern, M.D. 

Title and Role with Respect to the Research:
Physician and Principal Investigator

Name of Entity in which the Financial Interest is Held:
TechLab, Inc. 

Nature of the Interest that Constitutes a COI Disclosure:
The Covered Individual is a consultant for TechLab, Inc. The consulting fee Carilion Clinic receives on Dr. Bern’s behalf is in addition to his salary from Carilion Clinic. 

Approximate Value of the Financial Interest by Range, if Applicable:
$100,000 - $150,000

 

Jason Foerst, M.D. 

Title and Role with Respect to the Research:
Physician and Principal Investigator

Name of Entity in which the Financial Interest is Held:
Edwards Lifesciences

Nature of the Interest that Constitutes a COI Disclosure:
The Covered Individual is a proctor for Edwards Lifesciences, a medical equipment company that specializes in artificial heart valves and hemodynamic monitoring.  

Approximate Value of the financial interest by range, if applicable:
$0 - $4,999 

Section Title
Research Disclosure Information
Use Section Title As Header
On
Tab Name
Research Services and Resources
paragraphs
html blurb

RESEARCH DAY 2021

Carilion Clinic/Nursing/Fralin Biomedical Research Institute at VTC/VTC School of Medicine

WHEN: Tuesday, April 13

WHERE: Virtual Event Link:

https://carilion.webex.com/carilion/onstage/g.php?MTID=e2620dd12318e4a7659931a9483a64ef1

Event Password: Research2021

Virtual Poster Session Room:

For best viewing of the virtual poster session room, copy and paste the link(s) above into a web browser and follow the instructions. You will use your arrow keys and your A key to navigate through the two linked rooms. Thanks go to Kristy Collins, Fralin Life Sciences Institute; Leanna Blevins, Fralin Biomedical Research Institute; iTHRIV; and the poster presenters for introducing this experimental format for 2021 Research Day.

Abstract Information:

  • Plenary talks by residents, fellows, faculty, staff, undergraduates and graduate students
  • Poster sessions 
  • Keynote lecture
Section Title
Research Day 2021
Use Section Title As Header
Off
Tab Name
Research Day 2021
paragraphs
Tab Name
iTHRIV
paragraphs
Tab Name
Partnerships
Hero Image Categories
Building
Hero Image Selection
Option 2
Search Result Category